Shares of K2M Group Holdings Inc. (NASDAQ:KTWO) fell 0.8% during trading on Friday . The company traded as low as $15.85 and last traded at $15.91, with a volume of 65,780 shares trading hands. The stock had previously closed at $16.04.

A number of brokerages have commented on KTWO. Needham & Company LLC restated a “strong-buy” rating and set a $22.00 price target (up previously from $21.00) on shares of K2M Group Holdings in a research note on Friday, August 5th. Oppenheimer Holdings Inc. restated an “outperform” rating on shares of K2M Group Holdings in a research note on Tuesday, July 19th. Barclays PLC boosted their price target on shares of K2M Group Holdings from $20.00 to $22.00 and gave the company an “overweight” rating in a research note on Thursday, August 4th. Zacks Investment Research upgraded shares of K2M Group Holdings from a “sell” rating to a “hold” rating in a research note on Tuesday, August 9th. Finally, JMP Securities restated a “buy” rating and set a $22.00 price target on shares of K2M Group Holdings in a research note on Sunday, June 5th. Two equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the stock. The stock has a consensus rating of “Buy” and an average target price of $22.20.

The stock has a 50 day moving average of $16.71 and a 200-day moving average of $14.67. The stock’s market capitalization is $674.32 million.

K2M Group Holdings (NASDAQ:KTWO) last announced its quarterly earnings results on Wednesday, August 3rd. The medical device company reported ($0.27) EPS for the quarter, topping analysts’ consensus estimates of ($0.28) by $0.01. The business earned $59.20 million during the quarter, compared to analysts’ expectations of $57.47 million. The business’s revenue was up 5.0% compared to the same quarter last year. During the same period in the previous year, the business earned ($0.16) EPS. Equities research analysts expect that K2M Group Holdings Inc. will post ($1.10) earnings per share for the current year.

K2M Group Holdings, Inc is a medical device company focused on designing, developing and commercializing spine technologies and techniques. The Company’s spine products are used by spine surgeons to treat spinal pathologies, such as deformity (primarily scoliosis), trauma and tumor. The Company is engaged in designing, development and commercialization of products for patients suffering from degenerative spinal conditions.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.